首页> 美国卫生研究院文献>American Journal of Public Hygiene >Addressing Adolescent Immunization Disparities: A Retrospective Analysis of School-Based Health Center Immunization Delivery
【2h】

Addressing Adolescent Immunization Disparities: A Retrospective Analysis of School-Based Health Center Immunization Delivery

机译:解决青少年的免疫接种差异:对校本卫生中心免疫接种的回顾性分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectives. We compared completion rates for adolescent immunization series administered at school-based health centers (SBHCs) to completion rates for series administered at community health centers (CHCs) within a single integrated delivery system.Methods. We performed a retrospective analysis of data from an immunization registry for patients aged 12–18 years. Patients were assigned to either an SBHC or a CHC during the study interval based on utilization. We used bivariate analysis to compare immunization series completion rates between the 2 groups and multivariate analysis to compare risk factors for underimmunization. We performed subanalyses by ages 12–15 years versus ages 16–18 years for human papillomavirus (HPV) and for the combination of HPV; tetanus, diptheria, and pertussis (Tdap); and tetravalent meningococcus virus.Results. SBHC users had significantly higher completion rates (P < .001) for hepatitis B, Tdap, inactivated poliovirus, varicella, measles/mumps/rubella, and HPV for ages 16–18 years, and for the combination of HPV, Tdap, and MCV4 for ages 16–18 years. CHC users had higher completion rates for tetanus and diphtheria.Conclusions. SBHCs had higher completion rates than did CHCs for immunization series among those aged 12–18 years, despite serving a population with limited insurance coverage.
机译:目标。我们比较了在单一集成交付系统中在学校卫生中心(SBHC)实施的青少年免疫系列的完成率与在社区卫生中心(CHC)进行的系列免疫的完成率。我们对12-18岁患者的免疫登记数据进行了回顾性分析。根据使用情况,在研究间隔期间将患者分配为SBHC或CHC。我们使用双变量分析比较两组之间的免疫系列完成率,并使用多变量分析比较免疫不足的危险因素。我们按年龄12-15岁进行了子分析,而针对人乳头瘤病毒(HPV)和HPV组合进行了16-18岁。破伤风,白喉和百日咳(Tdap);和四价脑膜炎球菌病毒。 SBHC用户在16至18岁之间以及针对HPV,Tdap和MCV4组合使用的乙型肝炎,Tdap,灭活的脊髓灰质炎病毒,水痘,麻疹/腮腺炎/风疹和HPV的完成率(P <.001)显着更高适用于16-18岁。 CHC用户破伤风和白喉的完成率较高。尽管服务于保险范围有限的人群,但在12至18岁的人群中,SBHC的完成率要高于CHC的免疫系列。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号